跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Jansar 100 Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Jansar 100 Plus
Approved
STANDARD
Jansar 100 Plus
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d1520add2eb074a2
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
d1520add2eb074a2
Drug Approval Philippines Name
Jansar 100 Plus
Product Name
Jansar 100 Plus
Registration Number
DRP-5964-01
Brand Name
Jansar 100 Plus
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
100 mg/25 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Jjysrinn Trading Inc
Issuance Date
27 January 2023
Expiry Date
27 February 2028
Pharmacologic Category
Angiotensin-II-Receptor Blocker/Diuretic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d1520add2eb074a2
Type
Standard
Back to Philippines FDA Approvals